Hideo Osada Selected Research

Hideo Osada Research Topics

Disease

4	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 09/2014 - 04/2009
4	Glioma (Gliomas) 08/2012 - 04/2003
3	Stroke (Strokes) 01/2015 - 01/2013
3	Neoplasms (Cancer) 10/2014 - 03/2004
3	Brain Ischemia (Cerebral Ischemia) 09/2014 - 01/2013
3	Ischemic Stroke 01/2013 - 01/2012
2	Carotid Stenosis (Carotid Artery Stenosis) 12/2014 - 05/2013
2	Hemorrhage 12/2014 - 01/2013
2	Wounds and Injuries (Trauma) 10/2014 - 01/2013
2	Intracranial Vasospasm 09/2014 - 04/2009
2	Glioblastoma (Glioblastoma Multiforme) 01/2014 - 01/2013
2	Inflammation (Inflammations) 05/2013 - 01/2013
2	Hydrocephalus (Hydrocephaly) 03/2013 - 03/2013
2	Cerebral Infarction 03/2013 - 01/2013
2	Meningitis 03/2013 - 04/2009
2	Hematoma 03/2013 - 01/2013
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2013 - 01/2013
1	Communicable Diseases (Infectious Diseases) 11/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2015
1	Ulcer 12/2014
1	Exophthalmos (Proptosis) 11/2014
1	Optic Nerve Injuries 11/2014
1	Brain Injuries (Brain Injury) 09/2014
1	Insulin Resistance 05/2013
1	Hypertensive Intracranial Hemorrhage 03/2013
1	Cerebral Hemorrhage 03/2013
1	Infarction (Infarctions) 01/2013
1	Shock 01/2013
1	Intracranial Hypertension 01/2013
1	Pheochromocytoma 01/2011
1	Paresis (Hemiparesis) 01/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Broca Aphasia (Expressive Aphasia) 01/2011
1	Muscle Spasticity (Spastic) 04/2009
1	Choroid Plexus Carcinoma 05/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2002
1	Neoplasm Metastasis (Metastasis) 04/2002

Drug/Important Bio-Agent (IBA)

3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2015 - 01/2012
3	AdiponectinIBA 06/2014 - 01/2013
2	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 09/2014 - 04/2009
2	HydrogenIBA 09/2014 - 01/2013
2	Hormones (Hormone)IBA 05/2013 - 01/2013
2	salicylhydroxamic acid (SHAM)IBA 01/2013 - 01/2013
2	SolutionsIBA 01/2013 - 04/2009
2	Phosphotransferases (Kinase)IBA 08/2012 - 01/2010
1	LipidsIBA 12/2014
1	Temozolomide (Temodar)FDA LinkGeneric 01/2014
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2014
1	Hemoglobins (Hemoglobin)IBA 01/2013
1	Glutathione (Reduced Glutathione)IBA 01/2013
1	EdaravoneIBA 01/2013
1	Glutamic Acid (Glutamate)FDA Link 01/2013
1	Therapeutic UsesIBA 01/2013
1	Protein Kinases (Protein Kinase)IBA 08/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2012
1	Essential Amino AcidsIBA 08/2012
1	Cytostatic AgentsIBA 08/2012
1	Leucine (L-Leucine)FDA Link 08/2012
1	Mitogen-Activated Protein KinasesIBA 08/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2012
1	UDPglucose-Hexose-1-Phosphate Uridylyltransferase (Galactose 1 P Uridyltransferase)IBA 08/2012
1	Dabigatran FDA Link 01/2012
1	CatecholaminesIBA 01/2011
1	Thymidine KinaseIBA 01/2010
1	Ganciclovir (Cytovene)FDA LinkGeneric 01/2010
1	ProdrugsIBA 01/2010
1	MagnesiumIBA 04/2009
1	CarbohydratesIBA 05/2006
1	AntigensIBA 05/2006
1	Neuropilin-1IBA 03/2004
1	NeuropilinsIBA 03/2004
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2004
1	NimustineIBA 04/2003
1	hammerhead ribozymeIBA 04/2003
1	multidrug resistance-associated protein 1IBA 04/2003
1	Interleukin-10 (Interleukin 10)IBA 04/2002

Therapy/Procedure

5	Decompressive Craniectomy 03/2013 - 01/2013
3	Therapeutics 09/2014 - 01/2013
2	Drug Therapy (Chemotherapy) 11/2017 - 01/2013
2	Intravenous Administration 01/2015 - 01/2013
2	Carotid Endarterectomy 12/2014 - 05/2013
2	Decompression 11/2014 - 10/2014
2	Radiotherapy 01/2014 - 01/2013
1	Thrombolytic Therapy 01/2015
1	Intravenous Infusions 09/2014
1	Lasers (Laser) 01/2013
1	Anesthesia 01/2011
1	Intraperitoneal Injections 01/2010